— Know what they know.
/
Not Investment Advice

MGX NASDAQ

Metagenomi, Inc. Common Stock
1W: -11.3% 1M: -12.1% 3M: -18.4% YTD: -38.9% 1Y: -57.3%
$1.02
-0.09 (-7.69%)
 
Weekly Expected Move ±6.4%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $38.4M mcap · 25M float · 0.632% daily turnover · Short 43% of daily vol
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
44.4 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -268.2%
Cost Advantage
41
Intangibles
55
Switching Cost
53
Network Effect
39
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. MGX shows a Weak competitive edge (44.4/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. Negative ROIC of -268.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 4Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2024-08-21 H.C. Wainwright Mitchell Kapoor Initiated $7 — +112.1% $3.30
2024-03-28 Jefferies Maury Raycrof Initiated $22 — +98.4% $11.09

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
5
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. MGX receives an overall rating of C. Strongest factors: P/B (5/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-03-09 D+ C
2026-03-06 C D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
86
Earnings Quality
69
Growth
25
Value
42
Momentum
31
Safety
0
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-3.51
Distress Zone
Piotroski F-Score
1/9
✗ ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
-3.56
Bankruptcy prob: 2.8%
Low Risk
Credit Rating
BB
Score: 42.7/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.91x
Accruals: -3.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MGX scores -3.51, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MGX scores 1/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MGX's implied 2.8% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MGX receives an estimated rating of BB (score: 42.7/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.41x
PEG
0.07x
P/S
2.83x
P/B
0.34x
P/FCF
-0.52x
P/OCF
—
EV/EBITDA
0.43x
EV/Revenue
-2.81x
EV/EBIT
0.41x
EV/FCF
0.44x
Earnings Yield
-208.56%
FCF Yield
-191.45%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. MGX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.998
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
-6.906
EBIT / Rev
×
Asset Turnover
0.061
Rev / Assets
×
Equity Multiplier
1.446
Assets / Equity
=
ROE
-60.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MGX's ROE of -60.6% is driven by Asset Turnover (0.061), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 664 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.02
Median 1Y
$0.28
5th Pctile
$0.06
95th Pctile
$1.26
Ann. Volatility
91.2%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Jian Irish, Ph.D.,
M.B.A. President and Chief Executive Officer
 $570,655 $427,960 $1,667,920
Brian C. Thomas,
Ph.D. Former Chief Executive Officer
 $563,014 $42,240 $1,396,061
Pamela Wapnick, M.B.A.
Chief Financial Officer
 $464,000 $210,480 $934,964
Matthew L. Wein,
J.D. General Counsel, Compliance Officer, Head of BD&L and Corporate Secretary
 $407,151 $163,401 $756,384

CEO Pay Ratio

7:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,667,920
Avg Employee Cost (SGA/emp): $225,126
Employees: 119

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
119
-41.1% YoY
Revenue / Employee
$211,849
Rev: $25,210,000
Profit / Employee
$-738,387
NI: $-87,868,000
SGA / Employee
$225,126
Avg labor cost proxy
R&D / Employee
$793,555
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -9.1% -13.3% -21.4% -33.2% -31.9% -37.4% -40.9% -44.7% -49.0% -60.6% -60.61%
ROA -6.1% -9.3% -15.3% -24.0% -21.9% -26.5% -29.3% -32.2% -34.7% -41.9% -41.91%
ROIC 6.2% -2.1% -2.0% -2.2% -2.2% -2.1% -2.0% -2.0% -2.0% -2.7% -2.68%
ROCE -8.4% -13.8% -21.8% -30.9% -34.0% -38.4% -41.2% -46.4% -50.0% -64.1% -64.11%
Gross Margin -1.8% 1.0% 1.0% 1.0% 1.0% -1.6% 84.7% 66.8% 30.8% 1.0% 1.00%
Operating Margin -2.6% -84.3% -1.9% -2.1% -6.7% -2.5% -2.6% -6.2% -19.7% 112.0% 111.96%
Net Margin -2.3% -53.7% -1.6% -2.4% -6.1% -2.3% -2.4% -5.8% -18.5% 106.9% 106.93%
EBITDA Margin -2.5% -77.7% -1.8% -2.0% -6.4% -2.3% -2.2% -5.4% -17.4% 102.0% 102.01%
FCF Margin -2.8% -1.9% -2.0% -2.1% -2.3% -2.9% -3.0% -3.5% -3.9% -6.3% -6.33%
OCF Margin -2.7% -1.8% -1.9% -2.1% -2.3% -2.9% -3.0% -3.5% -3.9% -6.3% -6.30%
ROE 3Y Avg snapshot only -46.94%
ROA 3Y Avg snapshot only -31.70%
ROIC 3Y Avg snapshot only -1.14%
ROIC Economic snapshot only -52.96%
Cash ROA snapshot only -49.22%
Cash ROIC snapshot only -2.89%
CROIC snapshot only -2.90%
NOPAT Margin snapshot only -5.86%
Pretax Margin snapshot only -6.91%
R&D / Revenue snapshot only 6.44%
SGA / Revenue snapshot only 1.79%
SBC / Revenue snapshot only 77.60%
Valuation
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -15.72 -4.26 -1.46 -1.72 -0.65 -0.63 -1.00 -0.69 -0.59 -0.48 -0.410
P/S Ratio 35.42 4.90 1.87 2.56 1.11 1.63 2.86 2.42 2.26 3.30 2.832
P/B Ratio 1.43 0.57 0.31 0.57 0.24 0.28 0.50 0.38 0.37 0.40 0.341
P/FCF -12.85 -2.65 -0.93 -1.19 -0.48 -0.56 -0.96 -0.68 -0.58 -0.52 -0.522
P/OCF — — — — — — — — — — —
EV/EBITDA -4.18 2.29 2.31 0.82 1.60 1.24 0.64 0.68 0.62 0.43 0.431
EV/Revenue 10.39 -3.18 -3.48 -1.31 -2.90 -3.17 -1.74 -2.35 -2.27 -2.81 -2.812
EV/EBIT -3.99 2.16 2.18 0.77 1.50 1.17 0.60 0.64 0.58 0.41 0.407
EV/FCF -3.77 1.72 1.74 0.61 1.25 1.08 0.58 0.66 0.58 0.44 0.444
Earnings Yield -6.4% -23.5% -68.5% -58.3% -1.5% -1.6% -1.0% -1.4% -1.7% -2.1% -2.09%
FCF Yield -7.8% -37.8% -1.1% -83.8% -2.1% -1.8% -1.0% -1.5% -1.7% -1.9% -1.91%
PEG Ratio snapshot only 0.068
Price/Tangible Book snapshot only 0.398
EV/Gross Profit snapshot only -3.785
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 4.75 5.82 6.18 6.91 5.85 6.36 6.42 7.22 6.43 4.50 4.504
Quick Ratio 4.75 5.82 6.18 6.91 5.85 6.36 6.42 7.22 6.43 4.50 4.504
Debt/Equity 0.17 0.18 0.18 0.19 0.21 0.22 0.23 0.26 0.28 0.34 0.335
Net Debt/Equity -1.01 -0.94 -0.89 -0.86 -0.85 -0.83 -0.80 -0.76 -0.73 -0.74 -0.737
Debt/Assets 0.12 0.12 0.13 0.14 0.15 0.16 0.17 0.18 0.20 0.22 0.217
Debt/EBITDA -1.73 -1.11 -0.72 -0.55 -0.54 -0.50 -0.49 -0.47 -0.48 -0.43 -0.426
Net Debt/EBITDA 10.06 5.82 3.55 2.43 2.21 1.88 1.68 1.39 1.23 0.94 0.937
Interest Coverage — — — — — — — — — — —
Equity Multiplier 1.51 1.43 1.40 1.38 1.40 1.39 1.39 1.39 1.43 1.54 1.543
Cash Ratio snapshot only 4.367
Cash to Debt snapshot only 3.199
FCF to Debt snapshot only -2.275
Defensive Interval snapshot only 401.0 days
Efficiency & Turnover
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.03 0.08 0.12 0.16 0.13 0.10 0.10 0.09 0.09 0.06 0.061
Inventory Turnover — — — — — — — — — — —
Receivables Turnover 5.36 18.91 72.46 41.60 29.26 26.79 39.91 32.28 22.20 15.30 15.297
Payables Turnover 4.59 9.10 10.13 58.98 0.00 7.10 11.04 24.86 10.26 1.27 1.269
DSO 68 19 5 9 12 14 9 11 16 24 23.9 days
DIO 0 0 0 0 — 0 0 0 0 0 0.0 days
DPO 79 40 36 6 — 51 33 15 36 288 287.5 days
Cash Conversion Cycle -11 -21 -31 3 — -38 -24 -3 -19 -264 -263.7 days
Fixed Asset Turnover snapshot only 0.325
Cash Velocity snapshot only 0.112
Capital Intensity snapshot only 12.809
Growth (YoY)
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — 3.1% 8.3% -27.6% -51.8% -50.7% -59.8% -59.84%
Net Income — — — — -2.1% -1.4% -62.3% -12.6% -10.2% -7.3% -7.28%
EPS — — — — -2.1% -1.4% -59.8% -11.0% -8.5% -5.9% -5.85%
FCF — — — — -2.4% -71.4% -8.0% 20.3% 16.3% 13.3% 13.30%
EBITDA — — — — -2.0% -99.2% -31.5% -3.7% 0.3% -2.5% -2.54%
Op. Income — — — — -2.0% -1.0% -35.1% -8.0% -5.8% -9.5% -9.53%
OCF Growth snapshot only 11.88%
Asset Growth snapshot only -36.21%
Equity Growth snapshot only -42.52%
Debt Growth snapshot only -12.26%
Shares Change snapshot only 1.35%
Growth Quality
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — — — 0.10 0.64 0.641
Earnings Stability — — — — — — — — 0.85 0.83 0.832
Margin Stability — — — — — — — — 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.96 0.97 0.971
Earnings Smoothness — — — — — — — — — — —
ROE Trend — — — — — — — — -0.39 -0.54 -0.541
Gross Margin Trend — — — — — — — — 0.24 0.58 0.580
FCF Margin Trend — — — — — — — — -1.39 -3.94 -3.935
Sustainable Growth Rate — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.19 1.56 1.51 1.40 1.31 1.11 1.03 1.01 1.02 0.91 0.915
FCF/OCF 1.03 1.03 1.03 1.03 1.02 1.02 1.01 1.01 1.00 1.00 1.004
FCF/Net Income snapshot only 0.918
CapEx/Revenue 8.2% 5.1% 6.5% 6.0% 5.5% 5.8% 2.7% 2.3% 1.4% 2.3% 2.28%
CapEx/Depreciation snapshot only 0.060
Accruals Ratio 0.01 0.05 0.08 0.10 0.07 0.03 0.01 0.00 0.01 -0.04 -0.036
Sloan Accruals snapshot only -0.389
Cash Flow Adequacy snapshot only -276.657
Dividends & Buybacks
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — —
Chowder Number — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -21.9% -55.3% -1.1% -62.7% -5.0% -0.7% -0.1% -0.3% -0.4% -0.4% -0.37%
Total Shareholder Return -21.9% -55.3% -1.1% -62.7% -5.0% -0.7% -0.1% -0.3% -0.4% -0.4% -0.37%
DuPont Factors
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 0.94 0.93 0.93 0.94 0.96 0.99 1.00 1.00 1.00 0.998
Interest Burden (EBT/EBIT) 0.87 0.83 0.86 0.94 0.95 0.98 1.00 0.96 0.99 1.00 1.000
EBIT Margin -2.60 -1.47 -1.60 -1.70 -1.94 -2.72 -2.91 -3.65 -3.90 -6.91 -6.906
Asset Turnover 0.03 0.08 0.12 0.16 0.13 0.10 0.10 0.09 0.09 0.06 0.061
Equity Multiplier 1.51 1.43 1.40 1.38 1.46 1.41 1.40 1.39 1.41 1.45 1.446
Per Share
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.67 $-0.96 $-1.49 $-2.10 $-2.11 $-2.34 $-2.38 $-2.34 $-2.29 $-2.48 $-2.48
Book Value/Share $7.36 $7.19 $6.96 $6.33 $5.74 $5.27 $4.78 $4.22 $3.67 $2.99 $2.99
Tangible Book/Share $7.36 $7.19 $6.96 $6.33 $5.74 $5.27 $4.78 $4.22 $3.67 $2.99 $2.99
Revenue/Share $0.30 $0.83 $1.16 $1.41 $1.22 $0.91 $0.83 $0.67 $0.59 $0.36 $0.36
FCF/Share $-0.82 $-1.54 $-2.33 $-3.02 $-2.82 $-2.66 $-2.48 $-2.38 $-2.33 $-2.28 $-2.28
OCF/Share $-0.80 $-1.50 $-2.25 $-2.94 $-2.76 $-2.61 $-2.45 $-2.36 $-2.32 $-2.27 $-2.27
Cash/Share $8.74 $8.01 $7.47 $6.69 $6.10 $5.52 $4.93 $4.27 $3.73 $3.20 $3.20
EBITDA/Share $-0.74 $-1.16 $-1.75 $-2.25 $-2.22 $-2.32 $-2.26 $-2.30 $-2.18 $-2.35 $-2.35
Debt/Share $1.28 $1.28 $1.25 $1.23 $1.20 $1.16 $1.12 $1.08 $1.04 $1.00 $1.00
Net Debt/Share $-7.46 $-6.73 $-6.22 $-5.46 $-4.90 $-4.36 $-3.81 $-3.19 $-2.69 $-2.20 $-2.20
Academic Models
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — -3.505
Altman Z-Prime snapshot only -5.979
Piotroski F-Score 1 1 1 1 4 3 1 1 1 1 1
Beneish M-Score — — — — -4.26 -3.86 -1.74 -3.27 -0.26 — —
Ohlson O-Score snapshot only -3.563
ROIC (Greenblatt) snapshot only -67.62%
Net-Net WC snapshot only $1.68
EVA snapshot only $-82409440.00
Credit
Metric Trend Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB
Credit Score 53.90 49.39 44.45 49.23 42.79 43.07 42.75 42.71 43.00 42.74 42.739
Credit Grade snapshot only 12
Credit Trend snapshot only -0.336
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 38
Sector Credit Rank snapshot only 35

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms